BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Business

  St. Jude Children’s Research Hospital Patient Austin Set to Announce the Denver Broncos’ Round 1 Pick at the 2018 NFL Draft

  St. Jude Children’s Research Hospital® patient Austin will join NFL Commissioner Roger Goodell onstage at AT&T Stadium to announce the Denver Broncos’ Round 1 pick on Thursday, April 26.

  April 24, 2018

   · 

  3 min read
• FDA

  Quotient Limited Announces FDA Approval of Seven Blood Bank Reagents, Including Two Market Firsts

  The new products are Monoclonal Antisera and Anti-Human Globulin.

  April 24, 2018

   · 

  3 min read
• Business

  Puration Finalizes Acquisition Terms With Canadian Cannabis Cultivation Operator and Targets May 30th Closing Date

  Puration, Inc. announced finalizing the terms with a Canadian cannabis grow operator for the acquisition of a business intended to expand an existing medical marijuana grow operation in Canada.

  April 24, 2018

   · 

  2 min read
• Genetown

  David Rowan, Founding Editor-in-Chief of WIRED UK Magazine, to Deliver Opening Keynote on the Future of Digital Health at FutureLink Munich

  TraceLink Inc. announced David Rowan, Founding Editor-in Chief of WIRED Magazine, as the keynote speaker at FutureLink, taking place June 5 - 7 in Munich.

  April 24, 2018

   · 

  3 min read
• BioMidwest

  Rebiotix Presents Posters at ECCMID 2018 Highlighting Microbiome Health Index™ Value Potential and RBX2660 Phase 2 Clinical Program Data

  The posters add to the growing library of data recently published and presented by Rebiotix highlighting the company’s microbiome drug products, clinical programs, and pioneering research involving microbiome composition and health.

  April 24, 2018

   · 

  4 min read
• ASX/NASDAQ Announcement

  HNSCC and OPMD program update

  April 24, 2018

   · 

  11 min read
• Business

  Flexpoint Announces 2017 Year End Financials and Record Annual Revenue

  Full Year 2017 revenue increased 8.3% to $340,604 versus 2016 revenue of $314,494.

  April 24, 2018

   · 

  3 min read
• Drug Development

  Tarveda Therapeutics Announces Dosing of First Patient in Phase 1/2a Study of PEN-866 for Patients with Solid Malignancies

  Phase 2a trial of PEN-221 has initiated

  April 24, 2018

   · 

  5 min read
• Policy

  Argentum and Cosmo Settle Patent Dispute Over UCERIS®

  Argentum Pharmaceuticals LLC, a generic pharmaceutical company, announced that it has reached a settlement agreement with Cosmo Technologies Limited related to Argentum’s inter partes review petition challenging an Orange Book-listed patent for UCERIS® (budesonide).

  April 24, 2018

   · 

  1 min read
• Biotech Bay

  SomaGenics Announces Upcoming Data Presentations of Its Wound Healing Therapeutic Program

  SomaGenics, Inc. today announced two forthcoming presentations and a publication on preclinical results of its wound healing therapeutic program

  April 24, 2018

   · 

  2 min read